Skip to main content

2022 Workshop on Synuclein Pre-Formed Fibrils

In 2022, MJFF and the ASAP Initiative formed a working group to discuss improving robustness and reproducibility of the alpha-synuclein pre-formed fibril model. The workshop was divided into three section to cover (1) characterizing the protein injectate, (2) understanding the model and interpreting phenotypes, and (3) choosing between recombinant protein, brain homogenate, and amplified patient material as injectate. This document contains the discussion summary. 

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.